Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Amortization - Intangibles: 2024-2025

Historic Amortization - Intangibles for Fortress Biotech (FBIO) over the last 2 years, with Sep 2025 value amounting to $1.1 million.

  • Fortress Biotech's Amortization - Intangibles rose 30.71% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year change of. This contributed to the annual value of $3.4 million for FY2024, which is 9.89% down from last year.
  • Fortress Biotech's Amortization - Intangibles amounted to $1.1 million in Q3 2025, which was down 0.00% from $1.1 million recorded in Q2 2025.
  • Over the past 5 years, Fortress Biotech's Amortization - Intangibles peaked at $1.1 million during Q1 2025, and registered a low of $814,000 during Q1 2024.
  • Over the past 2 years, Fortress Biotech's median Amortization - Intangibles value was $981,000 (recorded in 2024), while the average stood at $945,143.
  • Data for Fortress Biotech's Amortization - Intangibles shows a peak YoY soared of 30.84% (in 2025) over the last 5 years.
  • Fortress Biotech's Amortization - Intangibles (Quarterly) stood at $981,000 in 2024, then surged by 30.71% to $1.1 million in 2025.
  • Its Amortization - Intangibles was $1.1 million in Q3 2025, compared to $1.1 million in Q2 2025 and $1.1 million in Q1 2025.